Javier de Castro

Efficacy, safety, and biomarker results of trastuzumab emtansine (T-DM1) in patients (pts) with previously treated HER2-overexpressing locally advanced or metastatic non-small cell lung cancer (mNSCLC).

L. Bubendorf, R. Stahel, S. Peters, 2017 .

Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP

J. R. Jarabo Sarceda, A. Martínez-Martí, R. Bernabé Caro, 2024, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].

E. Felip, J. D. Castro, L. Pijuan, 2020, Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia.

Priorities in Cardio-Oncology Basic and Translational Science

A. Ghigo, I. García-Lunar, P. Thavendiranathan, 2023, JACC. CardioOncology.